HTG Molecular Diagnostics Inc is a commercial stage company. It develops & markets a novel technology platform to facilitate the routine use of complex molecular profiling with its focus on clinical applications.
$4.17 -0.35 (-7.74%)
As of 01/26/2023 16:00:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.